Inventiva S.A. American Depository Shares (IVA) vs Rigel Pharmaceuticals (RIGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Rigel Pharmaceuticals (RIGL) has outperformed Inventiva S.A. American Depository Shares (IVA) over the past year, losing 13.3% versus a loss of 27.0%. Over five years, RIGL leads with a +44.7% price change compared with -76.5% for IVA. Rigel Pharmaceuticals is the larger company by market cap ($754.9 million vs $750.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IVA | RIGL |
|---|---|---|
| Share price | $3.14 | $40.09 |
| Market cap | $750.78M | $754.89M |
| 1-day change | -8.99% | -2.67% |
| YTD return | -32.47% | -6.40% |
| 1-year return | -26.98% | -13.26% |
| 5-year return | -76.53% | +44.73% |
| P/E ratio (TTM) | — | 2.49 |
| Forward P/E | — | 8.39 |
| EPS (TTM) | $-0.62 | $16.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $294.28M |
| Revenue growth (YoY) | — | +64.15% |
| Net income (latest FY) | $-49.63M | $367.02M |
| Gross margin | — | 93.33% |
| Operating margin | — | 42.63% |
| Net margin | — | 124.72% |
| 52-week high | $7.29 | $52.61 |
| 52-week low | $2.82 | $24.95 |
| Distance from 52-week high | -56.93% | -23.80% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +359.24% | +60.64% |
| Average volume | 2.40M | 248.06K |
| Shares outstanding | 239.10M | 18.83M |
| Employees | 87 | 172 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RIGL has outperformed IVA by 13.7 percentage points over the past year.
About Inventiva S.A. American Depository Shares
IVA stock →Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
About Rigel Pharmaceuticals
RIGL stock →Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; REZLIDHIA, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test; and GAVRETO, a once daily, small molecule, oral, kinase inhibitor for the treatment of adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC), as well as to treat adult and pediatric patients twelve years of age and older with advanced or metastatic RET fusion-positive thyroid cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 172 employees
IVA vs RIGL FAQ
Which is bigger, Inventiva S.A. American Depository Shares or Rigel Pharmaceuticals?
Rigel Pharmaceuticals (RIGL) is larger, with a market capitalization of $754.89M compared with $750.78M for Inventiva S.A. American Depository Shares (IVA).
Which stock has performed better over the past year, IVA or RIGL?
RIGL returned -13.26% over the past 12 months, compared with -26.98% for IVA (price return, excluding dividends). Past performance does not predict future results.
Are Inventiva S.A. American Depository Shares and Rigel Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.